Buy Cadila Healthcare, target Rs 248: Sagar Doshi
Buy Cadila Healthcare Ltd. at a price target of Rs 248.0 and a stoploss at Rs 216 from entry point.
Sagar Doshi of Edelweiss Financial Services has a buy call on Cadila Healthcare Ltd. with a target price of Rs 248. The current market price of Cadila Healthcare Ltd. is Rs 229.05. Time period given by the analyst is Intra Day when Cadila Healthcare Ltd. price can reach defined target. Sagar Doshi recommended to keep stoploss at Rs 216. Cadila Healthcare Ltd., incorporated in 1995, has a market cap of Rs 23448.48 crore.
Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 6207.00 Crore to Sales Value (95.59 % of Total Sales), Export Incentives which contributed Rs 169.30 Crore to Sales Value (2.60 % of Total Sales) and Other Operating Revenue which contributed Rs 116.40 Crore to Sales Value (1.79 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 3406.20 Crore, down -5.89 % from last quarter Sales of Rs 3619.50 Crore and up 23.03 % from last year same quarter Sales of Rs 2768.70 Crore Company has reported net profit after tax of Rs 314.80 Crore in latest quarter. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Bhadresh Shah, Mr.Ganesh N Nayak, Mr.Mukesh M Patel, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal, Ms.Nitin R Desai. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2019, the company has a total of 1,023,727,600 shares outstanding.
Cadila Healthcare Ltd. key Products/Revenue Segments include Pharmaceutical Products which contributed Rs 6207.00 Crore to Sales Value (95.59 % of Total Sales), Export Incentives which contributed Rs 169.30 Crore to Sales Value (2.60 % of Total Sales) and Other Operating Revenue which contributed Rs 116.40 Crore to Sales Value (1.79 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 30-06-2019, the company has reported a Consolidated sales of Rs 3406.20 Crore, down -5.89 % from last quarter Sales of Rs 3619.50 Crore and up 23.03 % from last year same quarter Sales of Rs 2768.70 Crore Company has reported net profit after tax of Rs 314.80 Crore in latest quarter. The company’s top management includes Dr.Sharvil P Patel, Mr.Apurva S Diwanji, Mr.Bhadresh Shah, Mr.Ganesh N Nayak, Mr.Mukesh M Patel, Mr.Pankaj R Patel, Ms.Dharmishta N Rawal, Ms.Nitin R Desai. Company has Deloitte Haskins & Sells LLP as its auditors. As on 30-06-2019, the company has a total of 1,023,727,600 shares outstanding.
Read this article in :Hindi